VHL gene mutation is common in clear cell renal cell carcinoma (ccRCC) patients causing upregulation of HIFα isoforms, so increasing the expression of the HIF2α target VEGF, in a manner apparently promoting tumorigenesis and cancer progression.31, 32. Here, EPAS1 is linked to nonpapillary renal cell carcinoma.